Fox Chase Cancer Center

This study is testing a modified schedule of two standard chemotherapy combinations (FOLFOX and FOLFIRI) for older adults (65+) with newly diagnosed, advanced pancreatic cancer that has spread. The main goal is to see if alternating these treatments every two weeks is easier for …

This study is testing whether combining two existing drugs, nivolumab and ramucirumab, can better control advanced lung cancer that has come back after prior treatment. It will enroll about 36 adults who have already tried at least one other therapy. The main goal is to see if th…

This study is testing whether giving an existing bladder cancer drug less frequently can still control the disease while potentially reducing side effects. The trial involves 60 adults with advanced bladder cancer who would normally receive standard treatment. Researchers want to…

This study is testing whether combining two existing drugs, nivolumab and axitinib, is safe and effective for treating advanced kidney cancer. It will involve about 98 patients, including those who have had prior treatment and those who have not. The first part finds the safest d…

This early-stage study is testing whether a lower, potentially safer dose of radiation can effectively treat advanced solid tumors when combined with a drug called 5-aminolevulinic acid (ALA). The drug is meant to make cancer cells more sensitive to the radiation, which could hel…